Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis

Molecular Immunology

Volumn 45, Issue 10, 2008, Pages 2962-2969

  Conlan, J Wayne ^a   Zhao, Xigeng ^a   Harris, Gregory ^a   Shen, Hua ^a   Bolanowski, Mark ^b   Rietz, Cecilia ^c   Sjostedt, Anders ^c   Chen, Wangxue ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b DynPort Vaccine Company LLC   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Chemokines; Cytokines; Francisella tularensis

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6;

ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRANCISELLA TULARENSIS; IMMUNE RESPONSE; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TULAREMIA; UPREGULATION;

AEROSOLS; ANIMALS; CHEMOKINES; DERMIS; FEMALE; FRANCISELLA TULARENSIS; GENE EXPRESSION REGULATION; KINETICS; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RESPIRATORY SYSTEM; RNA, MESSENGER; SPLEEN; TULAREMIA;

ANIMALIA; BACTERIA (MICROORGANISMS); FRANCISELLA; FRANCISELLA TULARENSIS; MUS;

EID: 41849089157     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.01.022     Document Type: Article

References (24)

1. Andersson H., Hartmanova B., KuoLee R., Ryden P., Conlan W., Chen W., and Sjostedt A. Transcriptional profiling of host response in mouse following aerosol infection with type A Fancisella tularensis. J. Med. Microbiol. 55 (2006) 263-271
2. Baskerville A., and Hambleton P. Pathogenesis and pathology of respiratory tularaemia in the rabbit. Br. J. Exp. Pathol. 57 (1976) 339-347
3. Baskerville A., Hambleton P., and Dowsett A.B. The pathology of untreated and antibiotic-treated tularaemia in monkeys. Br. J. Exp. Pathol. 59 (1978) 615-623
4. Borish L.C., and Steinke J.W. Cytokines and chemokines. J. Allergy Clin. Immunol. 111 (2003) S460-S475
5. Chen W., Shen H., Webb A., KuoLee R., and Conlan J.W. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen; protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine 21 (2003) 3690-3700
6. Chen W., KuoLee R., Shen H., and Conlan J.W. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. Microb. Pathog. 36 (2004) 311-318
7. Cole L.E., Elkins K.E., Michalek S.M., Quereshi N., Eaton L.J., Rallabhandi P., Cuesta N., and Vogel S.N. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J. Immunol. 176 (2006) 6888-6899
8. Conlan J.W., Shen H., Webb A., and Perry M.B. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugate to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20 (2002) 3465-3471
9. Conlan J.W., Chen W., Shen H., Webb A., and KuoLee R. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb. Pathog. 34 (2003) 239-248
10. Conlan J.W., Shen H., KuoLee R., Zhao X., and Chen W. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an αβ T cell- and interferon gamma-dependent mechanism. Vaccine 23 (2005) 2477-2485
11. Conlan J.W., and Oyston P.C.F. Vaccines against Francisella tularensis. Ann. NY Acad. Sci. 1105 (2007) 325-350
12. - T cells control intracellular bacterial infections both in vitro and in vivo. J. Exp. Med. 202 (2005) 309-319
13. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Friedlander A.M., Hauer J., Layton M., Lillibridge S.R., McDade J.E., Osterholm M.T., O'Toole T., Parker G., Perl T.M., Russell P.K., and Tonat K. Tularemia as a biological weapon: medical and public health management. JAMA 285 (2001) 2763-2773
14. Elenkov I.J., Lezzoni D.G., Daly A., Harris A.G., and Chrousos G.P. Cytokine dysregulation, inflammation, and well-being. Neuroimmunomodulation 12 (2005) 255-269
15. Ellis J., Oyston P.C.F., Green M., and Titball R.W. Tularemia Clin. Microbiol. Rev. 15 (2002) 631-646
16. Elkins K.E., Cowley S.C., and Bosio C.M. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microb. Infect. 5 (2003) 135-142
17. Fulop M., Mastroeni P., Green M., and Titball R.W. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19 (2001) 4465-4472
18. Johnson L.L., Bergren K.N., Szaba F.M., Chen W., and Smiley S.T. Fibrin-mediated protection against infection-stimulated immunopathology. J. Exp. Med. 197 (2003) 801-806
19. Lillie R.D., and Francis E. The pathology of tularemia. NIH Bull. 167 (1936) 1-217
20. Murdoch C., and Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95 (2000) 3032-3043
21. Shen H., Chen W., and Conlan J.W. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. Vaccine 22 (2004) 2116-2121
22. Sjostedt A. Tularemia: history, epidemiology, pathogen physiology and clinical manifestations. Ann. NY Acad. Sci. 1105 (2007) 1-29
23. Twine S.M., Shen H., Kelly J.F., Chen W., Sjostedt A., and Conlan J.W. Virulence comparison in mice of distinct isolates of type A Francisella tularensis. Microb. Pathog. 40 (2006) 133-138
24. Wu T.H., Hutt J.A., Garrison K.A., Berliba L.S., Zhou Y., and Lyons C.R. Intransal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis bovar A. Infect. Immunol. 73 (2005) 2644-2654